Kaygisiz Z, Dönmez T, Uyar R, Ertürk M, Soydan M
Department of Physiology, Faculty of Medicine, University of Osmangazi, Eskişehir, Turkey.
Ren Physiol Biochem. 1995 Jan-Feb;18(1):49-55. doi: 10.1159/000173898.
The mechanisms that mediate the actions of bradykinin on ureteral motility are poorly defined and mediation via prostaglandins has not been examined. Therefore, the effects of bradykinin on contractility and the possible mediator role of prostaglandins have been investigated in sheep ureter. At the concentrations of 10(-8), 10(-7) and 10(-6) M, bradykinin elicited marked reductions in contractile force. When ureteral strips were treated separately with 10(-6) M indomethacin, 2 x 10(-6) M sodium salicylate and 10(-5) M aspirin, each drug produced a significant decrease in contractile force. In strips in which prostaglandin synthesis was inhibited by the above concentrations of indomethacin, sodium salicylate and aspirin, 10(-7) M bradykinin significantly decreased the contractility. From these data, we concluded that in ureter bradykinin decreases contractility via a mechanism not involving prostaglandin generation.
缓激肽对输尿管运动的作用机制尚不明确,且尚未研究其通过前列腺素介导的情况。因此,我们研究了缓激肽对绵羊输尿管收缩性的影响以及前列腺素可能的介导作用。在10^(-8)、10^(-7)和10^(-6) M的浓度下,缓激肽可使收缩力显著降低。当输尿管条分别用10^(-6) M吲哚美辛、2×10^(-6) M水杨酸钠和10^(-5) M阿司匹林处理时,每种药物均使收缩力显著下降。在前列腺素合成被上述浓度的吲哚美辛、水杨酸钠和阿司匹林抑制的输尿管条中,10^(-7) M缓激肽可显著降低收缩性。根据这些数据,我们得出结论:在输尿管中,缓激肽通过不涉及前列腺素生成的机制降低收缩性。